Business
If you've been following the weight loss drug space, one name is dominating headlines in 2026: orforglipron. Sold under the brand name Founday , this once-daily oral pill developed by Eli Lilly is the first GLP-1 receptor agonist for weight loss that can be taken at any time of day — with or without food or water restrictions. The FDA gave it the green light on April 1, 2026, and the buzz hasn't stopped since. Here's everything you need to know.